SIG
XBI icon

Senator Investment Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Senator Investment Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-335,000
Closed -$19.8M – 66
2016
Q4 		$19.8M Buy
+335,000
New +$20.7M 0.3% 39

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Senator Investment Group's XBI Position: Q1 2017 in Review

Senator Investment Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2017, closing a stake of 335,000 shares — an estimated $19.8M sold.

Senator Investment Group first reported a position in XBI in Q4 2016 and held it in 1 quarter. The position peaked at $19.8M in Q4 2016. 292 funds tracked by Wall St. Rank hold XBI as of Q1 2017.

  • Senator Investment Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2017 after selling out during the quarter.
  • Senator Investment Group sold 335,000 State Street SPDR S&P Biotech ETF shares in Q1 2017, an estimated $19.8M.
  • Senator Investment Group first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 1 quarter.
  • Senator Investment Group's State Street SPDR S&P Biotech ETF position peaked at $19.8M in Q4 2016.
  • 292 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2017.

Based on Senator Investment Group's 13F filing for Q1 2017, filed 12 May 2017.